Immune Processes and Pathogenic Fibrosis in Ocular Chronic Graft-Versus-Host Disease and Clinical Manifestations after Allogeneic Hematopoietic Stem Cell Transplantation

Cornea ◽  
2010 ◽  
Vol 29 ◽  
pp. S68-S77 ◽  
Author(s):  
Yoko Ogawa ◽  
Shigeto Shimmura ◽  
Murat Dogru ◽  
Kazuo Tsubota
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Graft Versus Host Disease ◽  
Clinical Manifestations ◽  
Hematopoietic Stem ◽  
Host Disease ◽  
Graft Versus Host

scholarly journals Chronic “graft versus host” disease after allogeneic hematopoietic stem cell transplantation: basic characteristics, pathogenetic mechanisms, treatment strategies and problems of clinical practice

2020 ◽  
Vol 7 (2) ◽  
pp. 94-111
Author(s):  
E. B. Machneva ◽  
V. Yu. Panarina ◽  
T. Z. Aliev ◽  
D. V. Shevtsov ◽  
A. M. Suleymanova ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Graft Versus Host Disease ◽  
Clinical Manifestations ◽  
Hematopoietic Stem ◽  
Host Disease ◽  
Graft Versus Host

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for different spectrum of diseases. This type of treatment is constantly improving, but HSCT remains a risky procedure with various possible complications, the main is – chronic “graft versus host” disease (cGVHD). сGVHD is immune disregulation, and characterized by a variety of clinical manifestations that reflect the multiple underlying pathophysiology mechanisms. The study of cGVHD has now made great progress, but there’s still a lot of questions. General characteristics, risk-factors of development, clinical manifestations, pathogenesis of cGVHD will be discussed in this article. Clinical case presented in this article explains usage of basic and novel agents for cGVHD treatment, prevention criterions for treatment of cGVHD in children.

Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation

2016 ◽  
Vol 44 (10) ◽  
pp. 917-923 ◽  
Author(s):  
Jan-Moritz Doehn ◽  
Andreas Winkler ◽  
Zoya Kuzmina ◽  
Anastasiya Hladik ◽  
Hildegard Greinix ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Graft Versus Host Disease ◽  
Pentraxin 3 ◽  
Hematopoietic Stem ◽  
Host Disease ◽  
Graft Versus Host
Sign in / Sign up

Export Citation Format

Share Document